How people think about the chemicals in cigarette smoke: a systematic review

Journal of Behavioral Medicine

Volumn 40, Issue 4, 2017, Pages 553-564

  Morgan, Jennifer C ^a,b   Byron, M Justin ^a,b   Baig, Sabeeh A ^a,b   Stepanov, Irina ^c   Brewer, Noel T ^a,b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Additives; Chemicals; Communication; Constituents; Ingredients; Tobacco

Indexed keywords

ATTITUDE TO HEALTH; AWARENESS; HUMAN; SMOKE; SMOKING; TOBACCO;

AWARENESS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; SMOKE; SMOKING; TOBACCO;

EID: 85013372003     PISSN: 01607715     EISSN: 15733521     Source Type: Journal    
DOI: 10.1007/s10865-017-9823-5     Document Type: Review

References (96)

1. Arnett, J. J. (1999). Winston’s” No Additives” campaign:” straight up”?” no bull”? Public Health Reports, 114, 522.
2. Bansal, M. A., Cummings, K. M., Hyland, A., Bauer, J. E., Hastrup, J. L., & Steger, C. (2004a). Do smokers want to know more about the cigarettes they smoke? Results from the EDUCATE study. Nicotine & Tobacco Research, 6, S289–S302. doi:10.1080/14622200412331320699
3. Bansal, M. A., Cummings, K. M., Hyland, A., & Giovino, G. A. (2004b). Stop-smoking medications: Who uses them, who misuses them, and who is misinformed about them? Nicotine & Tobacco Research, 6, S303–S310. doi:10.1080/14622200412331320707
4. Bansal-Travers, M., Cummings, K. M., Hyland, A., Brown, A., & Celestino, P. (2010). Educating smokers about their cigarettes and nicotine medications. Health Education Research, 25, 678–686. doi:10.1093/her/cyp069
5. Benowitz, N. L. (2001). Compensatory smoking of low-yield cigarettes. In D. R. Shopland (Ed.), Risks associated with smoking cigarettes with low machine yields of tar and nicotine (pp. 39–63). Rockville, MD: U.S. Department of Health and Human Services.
6. Benowitz, N. L. (2003). Cigarette smoking and cardiovascular disease: Pathophysiology and implications for treatment. Progress in Cardiovascular Diseases, 46, 91–111. doi:10.1016/S0033-0620(03)00087-2
7. Berman, M. L., Byron, M. J., Hemmerich, N., Lindblom, E. N., Lazard, A. J., Peters, E., & Brewer, N. T. (in press). Communicating tobacco product information to the public. Food and Drug Law Journal.
8. Biener, L., Nyman, A. L., Stepanov, I., & Hatsukami, D. (2014). Public education about the relative harm of tobacco products: An intervention for tobacco control professionals. Tobacco Control, 23, 385–388. doi:10.1136/tobaccocontrol-2012-050814
9. Borgida, E., Loken, B., Williams, A. L., Vitriol, J., Stepanov, I., & Hatsukami, D. (2015). Assessing constituent levels in smokeless tobacco products: A new approach to engaging and educating the public. Nicotine & Tobacco Research, 17, 1354–1361. doi:10.1093/ntr/ntv007
10. Borland, R., & Hill, D. (1997). Initial impact of the new Australian tobacco health warnings on knowledge and beliefs. Tobacco Control, 6, 317–325.
11. Borrelli, B., & Novak, S. P. (2007). Nurses’ knowledge about the risk of light cigarettes and other tobacco “harm reduction” strategies. Nicotine & Tobacco Research, 9, 653–661. doi:10.1080/14622200701365202
12. Bostrom, A., Fischhoff, B., & Morgan, M. G. (1992). Characterizing mental models of hazardous processes: A methodology and an application to radon. Journal of Social Issues, 48, 85–100. doi:10.1111/j.1540-4560.1992.tb01946.x
13. Boynton, M. H., Agans, R. P., Bowling, J. M., Brewer, N. T., Sutfin, E. L., Goldstein, A. O., et al. (2016). Understanding how perceptions of tobacco constituents and the FDA relate to effective and credible tobacco risk messaging: A national phone survey of U.S. adults, 2014–2015. BMC Public Health, 16, 516. doi:10.1186/s12889-016-3151-5
14. Brewer, N. T., Morgan, J. C., Baig, S. A., Mendel, J. R., Boynton, M. H., Pepper, J. K., et al. (2016). Public understanding of cigarette smoke constituents: Three United States surveys. Tobacco Control. doi:10.1136/tobaccocontrol-2015-052897
15. Carter, S. M., & Chapman, S. (2006). Smokers and non-smokers talk about regulatory options in tobacco control. Tobacco Control, 15, 398–404.
16. Chaaya, M., Jabbour, S., El-Roueiheb, Z., & Chemaitelly, H. (2004). Knowledge, attitudes, and practices of argileh (water pipe or hubble-bubble) and cigarette smoking among pregnant women in Lebanon. Addictive Behaviors, 29, 1821–1831. doi:10.1016/j.addbeh.2004.04.008
17. Cohen, J. B. (1996). Smokers’ knowledge and understanding of advertised tar numbers: Health policy implications. American Journal of Public Health, 86, 18–24. doi:10.2105/ajph.86.1.18
18. Counts, M., Hsu, F., Laffoon, S., Dwyer, R., & Cox, R. (2004). Mainstream smoke constituent yields and predicting relationships from a worldwide market sample of cigarette brands: ISO smoking conditions. Regulatory Toxicology and Pharmacology, 39, 111–134.
19. Crawford, M. A., Balch, G. I., & Mermelstein, R. (2002). Responses to tobacco control policies among youth. Tobacco Control, 11, 14–19.
20. Cummings, K. M., Hyland, A., Bansal, M. A., & Giovino, G. A. (2004a). What do Marlboro Lights smokers know about low-tar cigarettes? Nicotine & Tobacco Research, 6, S323–S332. doi:10.1080/14622200412331320725
21. Cummings, K. M., Hyland, A., Giovino, G. A., Hastrup, J. L., Bauer, J. E., & Bansal, M. A. (2004b). Are smokers adequately informed about the health risks of smoking and medicinal nicotine? Nicotine & Tobacco Research, 6, S333–S340. doi:10.1080/14622200412331320734
22. Czoli, C. D., & Hammond, D. (2014). Cigarette packaging: Youth perceptions of “natural” cigarettes, filter references, and contraband tobacco. Journal of Adolescent Health, 54, 33–39. doi:10.1016/j.jadohealth.2013.07.016
23. Ding, Y. S., Ashley, D. L., & Watson, C. H. (2007). Determination of 10 carcinogenic polycyclic aromatic hydrocarbons in mainstream cigarette smoke. Journal of Agricultural and Food Chemistry, 55, 5966–5973.
24. Djordjevic, M. V., Stellman, S. D., & Zang, E. (2000). Doses of nicotine and lung carcinogens delivered to cigarette smokers. Journal of the National Cancer Institute, 92, 106–111.
25. Downs, J. S., de Bruin, W. B., & Fischhoff, B. (2008). Parents’ vaccination comprehension and decisions. Vaccine, 26, 1595–1607.
26. Environics Research Group. (1996a). Public attitudes toward toxic constituent labelling on cigarette packages: Qualitative research report. Ottawa, Ontario: Health Canada.
27. Environics Research Group. (1996b). Public attitudes toward the listing of toxic ingredients on cigarette packages: A survey report. Ottawa, Ontario: Health Canada.
28. Environics Research Group. (2003a). Summary report of four focus groups in Toronto & Montréal on awareness and understanding on toxic emissions information on tobacco packaging: Final report. Ottawa, Ontario: Health Canada.
29. Environics Research Group. (2003b). Toxics information on cigarette packaging: Results of a survey of smokers. Ottawa, Ontario: Health Canada.
30. Etter, J. F. (2007). Informing smokers on additives in cigarettes: A randomized trial. Patient Education and Counseling, 66, 188–191. doi:10.1016/j.pec.2006.12.001
31. Etter, J. F., Kozlowski, L. T., & Perneger, T. V. (2003). What smokers believe about light and ultralight cigarettes. Preventive Medicine, 36, 92–98.
32. Family Smoking Prevention and Tobacco Control Act (2009). Public Law 111–31 [H.R. 1256].
33. Fathelrahman, A. I., Omar, M., Awang, R., Cummings, K. M., Borland, R., & Samin, A. S. B. M. (2010). Impact of the new Malaysian cigarette pack warnings on smokers’ awareness of health risks and interest in quitting smoking. International Journal of Environmental Research and Public Health, 7, 4089–4099. doi:10.3390/ijerph7114089
34. Feng, Z., Hu, W., Hu, Y., & Tang, M.-S. (2006). Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proceedings of the National Academy of Sciences, 103, 15404–15409. doi:10.1073/pnas.0607031103
35. Fischhoff, B., Slovic, P., & Lichtenstein, S. (1982). Lay foibles and expert fables in judgments about risk. The American Statistician, 36, 240–255.
36. Framework Convention on Tobacco Control. (2003). The World Health Organization. Retrieved from http://www.who.int/gb/fctc/PDF/inb6/einb65.pdf
37. Gallopel-Morvan, K., Moodie, C., Hammond, D., Eker, F., Beguinot, E., & Martinet, Y. (2011). Consumer understanding of cigarette emission labelling. European Journal of Public Health, 21, 373–375. doi:10.1093/eurpub/ckq087
38. Gilpin, E. A., Emery, S., White, M. M., & Pierce, J. P. (2002). Does tobacco industry marketing of ‘light’cigarettes give smokers a rationale for postponing quitting? Nicotine & Tobacco Research, 4, S147–S155.
39. Gori, G. B. (1990). Consumer perception of cigarette yields: Is the message relevant? Regulatory Toxicology and Pharmacology, 12, 64–68. doi:10.1016/s0273-2300(05)80047-9
40. Hall, M. G., Ribisl, K. M., & Brewer, N. T. (2014). Smokers’ and nonsmokers’ beliefs about harmful tobacco constituents: Implications for FDA communication efforts. Nicotine & Tobacco Research, 16, 343–350. doi:10.1093/ntr/ntt158
41. Hammond, D., Fong, G., McNeill, A., Borland, R., & Cummings, K. M. (2006). Effectiveness of cigarette warning labels in informing smokers about the risks of smoking: Findings from the International Tobacco Control (ITC) Four Country Survey. Tobacco Control, 15, iii19–iii25.
42. Hammond, D., & White, C. M. (2012). Improper disclosure: Tobacco packaging and emission labelling regulations. Public Health, 126, 613–619. doi:10.1016/j.puhe.2012.03.012
43. Hassan, L. M., & Shiu, E. (2013). No place to hide: Two pilot studies assessing the effectiveness of adding a health warning to the cigarette stick. Tobacco Control. doi:10.1136/tobaccocontrol-2013-051238
44. Hecht, S. S. (1998). Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chemical Research in Toxicology, 11, 559–603. doi:10.1021/tx980005y
45. Hecht, S. S. (1999). Tobacco smoke carcinogens and lung cancer. Journal of the National Cancer Institute, 91, 1194–1210.
46. Hecht, S. S. (2003). Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nature Reviews Cancer, 3, 733–744.
47. Hecht, S. S. (2012). Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control Act. Nicotine & Tobacco Research, 14, 18–28.
48. Hecht, S. S., Chen, C., Dong, M., Ornaf, R. M., Hoffmann, D., & Tso, T. (1977). Chemical studies on tobacco smoke: LI: Studies on non-volatile nitrosamines in tobacco. Beiträge zur Tabakforschung/Contributions to Tobacco Research, 9, 1–6. doi:10.2478/cttr-2013-0419
49. Hoffmann, D., Hecht, S. S., Ornaf, R. M., Wynder, E. L., & Tso, T. C. (1976). Chemical studies on tobacco smoke. XLII. Nitrosonornicotine: Presence in tobacco, formation and carcinogenicity. IARC Scientific Publication, 14, 307–320.
50. Hoffmann, D., Hoffmann, I., & El-Bayoumy, K. (2001). The less harmful cigarette: A controversial issue. A tribute to Ernst L. Wynder. Chemical Research in Toxicology, 14, 767–790.
51. Hukkanen, J., Jacob, P., & Benowitz, N. L. (2005). Metabolism and disposition kinetics of nicotine. Pharmacological Reviews, 57, 79–115.
52. International Agency for Research on Cancer. (1995). Dry cleaning, some chlorinated solvents and other industrial chemicals. In IARC monographs on the evaluation of carcinogenic risks to humans, 63.
53. International Agency for Research on Cancer. (1999). Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. In IARC monographs on the evaluation of carcinogenic risks to humans, 71.
54. International Agency for Research on Cancer. (2004). Tobacco smoke and involuntary smoking. In IARC monographs on the evaluation of carcinogenic risks to humans, 83.
55. International Agency for Research on Cancer. (2007). Smokeless tobacco and some tobacco-specific N-nitrosamines. In IARC monographs on the evaluation of carcinogenic risks to humans, 89.
56. International Agency for Research on Cancer. (2010a). Some aromatic amines, organic dyes, and related exposures. In IARC monographs on the evaluation of carcinogenic risks to humans, 99.
57. International Agency for Research on Cancer. (2010b). Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. In IARC monographs on the evaluation of carcinogenic risks to humans, 92.
58. International Agency for Research on Cancer. (2012a). Arsenic, metals, fibres, and dusts. In IARC monographs on the evaluation of carcinogenic risks to humans, 100C.
59. International Agency for Research on Cancer. (2012b). Chemical agents and related occupations. In IARC monographs on the evaluation of carcinogenic risks to humans, 100F.
60. Ipsos-Eureka. (2009). Public health value of disclosed cigarette ingredients and emissions data. Phillip: Department of Health and Ageing.
61. Kelley, D. E., Boynton, M., Noar, S. M., Morgan, J., Mendel, J., Ribisl, K. M., & Brewer, N. T. (2016). Identifying effective elements for disclosure messages about harmful constituents. Poster session presented at the 37th Annual Meeting of the Society of Behavioral Medicine, Washington, D.C.
62. Kelly, K. J., & Manning, K. (2014). The effects of natural cigarette claims on adolescents’ brand-related beliefs, attitudes, and intentions. Journal of Health Communication, 19, 1064–1075. doi:10.1080/10810730.2013.872720
63. Lewandowsky, S., Ecker, U. K., Seifert, C. M., Schwarz, N., & Cook, J. (2012). Misinformation and its correction continued influence and successful debiasing. Psychological Science in the Public Interest, 13, 106–131.
64. Maharik, M., & Fischhoff, B. (1992). The risks of using nuclear energy sources in space: Some lay activists’ perceptions. Risk Analysis, 12, 383–392.
65. McDaniel, P. A., & Malone, R. E. (2007). “I always thought they were all pure tobacco”: American smokers’ perceptions of “natural” cigarettes and tobacco industry advertising strategies. Tobacco Control, 16, e7. doi:10.1136/tc.2006.019638
66. Mooney, M. E., Leventhal, A. M., & Hatsukami, D. K. (2006). Attitudes and knowledge about nicotine and nicotine replacement therapy. Nicotine & Tobacco Research, 8, 435–446. doi:10.1080/14622200600670397
67. Moracco, K. E., Morgan, J. C., Mendel, J., Teal, R., Noar, S. M., Ribisl, K. M., et al. (2016). “My first thought was croutons:” Perceptions of cigarettes and cigarette smoke constituents among adult smokers and nonsmokers. Nicotine & Tobacco Research, 18, 1566–1574. doi:10.1093/ntr/ntv281
68. Mullins, R., & Borland, R. (1992). Evaluation of the what’s your poison? campaign. In R. Mullins (Ed.), Quit evaluation studies (Vol. 6). Melbourne: Anti-Cancer Council of Victoria.
69. National Research Council of the National Academies. (2008). Combined exposures to hydrogen cyanide and carbon monoxide in Army operations: Initial report. Retrieved from Washington (DC)
70. Noar, S. M., Kelley, D. E., Boynton, M., Morgan, J., Hall, M., Mendel, J., Ribisl, K. M., & Brewer, N. T. (2016). Perceived effectiveness of cigarette pack constituent disclosures: A randomized experiment. Poster session presented at the 22nd Annual Meeting of the Society for Research on Nicotine and Tobacco, Chicago, IL.
71. O’connor, R. J., Kozlowski, L. T., Borland, R., Hammond, D., & McNeill, A. (2006). Relationship between constituent labelling and reporting of tar yields among smokers in four countries. Journal of Public Health, 28, 324–329. doi:10.1093/pubmed/fdl056
72. Osman, A., Thrasher, J. F., Arillo-Santillan, E., & Regalado-Pineda, J. (2013). Cigarette-pack warnings, knowledge about tobacco constituents, and quit behavior: A population-based longitudinal study of Mexican smokers. Paper presented at the Society for Research on Nicotine and Tobacco, Boston, MA.
73. Osman, A., Thrasher, J. F., Cayir, E., Hardin, J. W., Perez-Hernandez, R., & Froeliger, B. (2016). Depressive symptoms and responses to cigarette pack warning labels among Mexican smokers. Health Psychology, 35, 442–453. doi:10.1037/hea0000298
74. Perez, C. M., Ledbetter, A. D., Hazari, M. S., Haykal-Coates, N., Carll, A. P., Winsett, D. W., et al. (2013). Hypoxia stress test reveals exaggerated cardiovascular effects in hypertensive rats after exposure to the air pollutant acrolein. Toxicological Sciences, 132(2), 467–477.
75. Pfeifer, G. P., Denissenko, M. F., Olivier, M., Tretyakova, N., Hecht, S. S., & Hainaut, P. (2002). Tobacco smoke carcinogens, DNA damage and p 53 mutations in smoking-associated cancers. Oncogene, 21, 7435–7451.
76. Reddy, P., Meyer-Weitz, A., & Yach, D. (1996). Smoking status, knowledge of health effects and attitudes towards tobacco control in South Africa. South African Medical Journal, 86, 1389–1393.
77. Rodgman, A., & Perfetti, T. A. (2013). The chemical components of tobacco and tobacco smoke (2nd ed.). New York: CRC Press.
78. Schmeltz, I., & Hoffmann, D. (1977). Nitrogen-containing compounds in tobacco and tobacco smoke. Chemical Reviews, 77, 295–311.
79. Siahpush, M., McNeill, A., Hammond, D., & Fong, G. (2006). Socioeconomic and country variations in knowledge of health risks of tobacco smoking and toxic constituents of smoke: Results from the 2002 International Tobacco Control (ITC) Four Country Survey. Tobacco Control, 15, iii65–iii70.
80. Stea, F., Bianchi, F., Cori, L., & Sicari, R. (2014). Cardiovascular effects of arsenic: Clinical and epidemiological findings. Environmental Science and Pollution Research, 21, 244–251. doi:10.1007/s11356-013-2113-z
81. Swayampakala, K., Thrasher, J. F., Hammond, D., Yong, H. H., Bansal-Travers, M., Krugman, D., et al. (2015). Pictorial health warning label content and smokers’ understanding of smoking-related risks-a cross-country comparison. Health Education Research, 30, 35–45. doi:10.1093/her/cyu022
82. The European Parliment and the Council of the Eurpoean Union. (2014). Revision of the Tobacco Products Directive. Official Journal of the European Union. doi:http://ec.europa.eu/health/tobacco/docs/dir_201440_en.pdf
83. Thrasher, J. F., Huang, L., Pérez-Hernández, R., Niederdeppe, J., Arillo-Santillán, E., & Alday, J. (2011). Evaluation of a social marketing campaign to support Mexico City’s comprehensive smoke-free law. American Journal of Public Health, 101, 328–335. doi:10.2105/ajph.2009.189704
84. Thrasher, J. F., Murukutla, N., Pérez-Hernández, R., Alday, J., Arillo-Santillán, E., Cedillo, C., et al. (2013). Linking mass media campaigns to pictorial warning labels on cigarette packages: A cross-sectional study to evaluate effects among Mexican smokers. Tobacco Control, 22, e57–e65. doi:10.1136/tobaccocontrol-2011-050282
85. U.S. Department of Health and Human Services. (2001). Hazardous substances data bank (HSDB online database). Retrieved from http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB
86. U.S. Department of Health and Human Services. (2004). Toxicological profile for ammonia. Public Health Service Agency for Toxic Substances and Disease Registry. http://wwwatsdr.cdc.gov/toxprofiles/tp126.pdf
87. U.S. Department of Health and Human Services. (2010). How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease: A report of the Surgeon General. Atlanta, GA: US.
88. U.S. Department of Health and Human Services. (2014). The health consequences of smoking—50 years of progress: A report of the Surgeon General. Rockville, MD: US.
89. U.S. Food and Drug Administration. (2012). Harmful and potentially harmful constituents in tobacco products and tobacco smoke; established list. Federal Register, 77, 20034–20037.
90. U.S. Food and Drug Administration. (2015). FDA takes action against three tobacco manufacturers for making “additive-free” and/or “natural” claims on cigarette labeling. [Press release]. Retrieved from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm459840.htm
91. U.S. Food and Drug Administration. (2016a). Major activities table. Retrieved from http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/BudgetReports/UCM437623.pdf
92. U.S. Food and Drug Administration. (2016b). Research priorities. Retrieved from http://www.fda.gov/TobaccoProducts/PublicHealthScienceResearch/Research/ucm311860.htm
93. WHO Working Group. (2014). Partial guidelines for implementation of the Articles 9 and 10 of the WHO framework convention on tobacco control (regulation of the content of tobacco products and regulation of tobacco product disclosures). Geneva, Switzerland
94. Wikmans, T., & Ramström, L. (2010). Harm perception among Swedish daily smokers regarding nicotine, NRT-products and Swedish Snus. Tobacco Induced Diseases, 8, 1. doi:10.1186/1617-9625-8-9
95. Willems, E. W., Rambali, B., Vleeming, W., Opperhuizen, A., & van Amsterdam, J. G. (2006). Significance of ammonium compounds on nicotine exposure to cigarette smokers. Food and Chemical Toxicology, 44, 678–688. doi:10.1016/j.fct.2005.09.007
96. Wiseman, K. D., Cornacchione, J., Wagoner, K. G., Noar, S. M., Moracco, K. E., Teal, R., et al. (2016). Adolescents’ and young adults’ knowledge and beliefs about constituents in novel tobacco products. Nicotine & Tobacco Research. doi:10.1093/ntr/ntw009